CTRI/2015/11/006342已完成3 期
Efficacy and safety of sevelamer carbonate vs. calcium acetate in patients with chronic renal disease on dialysis
emcure pharmaceuticals0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with the diagnosis of chronic renal disease undergoing hemodialysis for at least 6 weeks
排除标准
- •Hypercalcaemia, Significant gastrointestinal disorder (including known active peptic ulcer, Crohnâ??s disease, ulcerative colitis, irritable bowel syndrome, GI motility disorder),Current malignancy, Pregnant and lactating women, Known hypersensitivity to phosphate binders
研究者
相似试验
已完成
3 期
Comparison of Sevelamer and Calcium carbonat on magnesium serum level in hemodialyzed patientsIRCT20180831040912N1Semnan University of Medical Sciences60
已完成
3 期
Comparing the effect of sevelamer carbonate and sevelamer hydrochloride on blood level of phosphate, Ca, ph, bicarbonate and gastrointestinal complications in patients undergoing maintenance hemodialysisIRCT20141016019554N13Zanjan University of Medical Sciences44
已完成
4 期
Comparing the Effect of Sevelamer Hydrochloride and Calcium Carbonate on Serum Level of Inflammatory Markers in Hemodialysis PatientsIRCT20200724048193N1Tabriz University of Medical Sciences40
尚未招募
4 期
Ferric citrate vs. sevelamer carbonate (used for high phosphate ) as a phosphate binder drug in patients with chronic kidney disease on hemodialysis.CTRI/2024/04/066516Christian Medical College and Hospital, Ludhiana
尚未招募
不适用
Comparison of Ferric Citrate and Sevelamer in the treatment of high phosphate level in patients with Chronic Kidney DiseaseCTRI/2021/11/037748il